In this review:
Crizanlizumab in sickle cell disease
CLL – new targeted therapies
European mantle cell network – pros and cons of treatment
Nodular lymphocyte predominant Hodgkin’s lymphoma
Ruxolitinib in myelofibrosis
Luspatercept in β-thalassemia
D-KRd in newly diagnosed MM
Selinexor + dexamethasone in MM
Pegylated interferon alfa-2a in ET or PV
CC-122 + obinutuzumab in B-cell NHL
Please login below to download this issue (PDF)